P2Y12 inhibitor monotherapy in patients undergoing percutaneous coronary intervention
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine
Link
https://www.nature.com/articles/s41569-022-00725-6.pdf
Reference115 articles.
1. Valgimigli, M. et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS. Eur. Heart J. 39, 213–260 (2018).
2. Levine, G. N. et al. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J. Am. Coll. Cardiol. 68, 1082–1115 (2016).
3. Neumann, F.-J. et al. 2018 ESC/EACTS guidelines on myocardial revascularization. Eur. Heart J. 40, 87–165 (2019).
4. Lawton, J. S. et al. 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 145, e18–e114 (2022).
5. Angiolillo, D. A., Galli, M., Collet, J.-P., Kastrati, A. & O’Donoghue, M. O. Antiplatelet therapy after percutaneous coronary intervention. EuroIntervention 17, e1371–e1396 (2022).
Cited by 47 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Considerations in Antiplatelet Therapy in Women Undergoing Treatment of Acute Coronary Syndrome or Percutaneous Coronary Intervention;Interventional Cardiology Clinics;2024-10
2. Proteomic Evaluation of the Thrombosis-inflammation Interplay in STEMI with MVO;2024-08-11
3. Current Management of Non-ST-Segment Elevation Acute Coronary Syndrome;Biomedicines;2024-08-02
4. P2Y12 inhibitor monotherapy after short DAPT in acute coronary syndrome: a systematic review and meta-analysis;European Heart Journal - Cardiovascular Pharmacotherapy;2024-07-25
5. P2Y12 Receptor Inhibitor for Antiaggregant Therapies: From Molecular Pathway to Clinical Application;International Journal of Molecular Sciences;2024-07-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3